Evidence map›Paper›PMID 21073165›Full record

ArticleBiochemistry2010

Speciated human high-density lipoprotein protein proximity profiles.

Kekulawalage Gauthamadasa, Corina Rosales, Henry J Pownall, Stephen Macha, W Gray Jerome, Rong Huang, R A Gangani D Silva

Abstract read
In one paragraph

Article in Biochemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Kekulawalage GauthamadasaDepartment of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, Ohio 45237, United States.
Corina Rosales
Henry J Pownall
Stephen Macha
W Gray Jerome
Rong Huang
R A Gangani D Silva
University of Cincinnati · USBaylor College of Medicine · USVanderbilt University Medical Center · US

Funding

Therapeutic Approaches to Dysregulated HDL MetabolismR01HL056865 · NHLBI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI POWNALL, HENRY J. · 1997 to 2015
$5.2M
ENZYMIC REACTIONS OF MODEL PLASMA LIPOPROTEINSR01HL030914 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI POWNALL, HENRY J. · 1985 to 2010
$2.2M
The role of apolipoprotein A-II in the modulation of HDL functionR00HL087561 · NHLBI · UNIVERSITY OF CINCINNATI · PI SILVA, RANASINGHE · 2009 to 2011
$742k
The Role of Apolipoprotein A-II in the Modulation of HDL FunctionK99HL087561 · NHLBI · UNIVERSITY OF CINCINNATI · PI SILVA, RANASINGHE · 2007 to 2008
$174k
NHLBI NIH HHS HL030914NHLBI NIH HHS HL056865NHLBI NIH HHS HL087561NHLBI NIH HHS K99 HL087561NHLBI NIH HHS R00 HL087561NHLBI NIH HHS R01 HL030914NHLBI NIH HHS R01 HL056865
6 · The paper itself

Abstract

It is expected that the attendant structural heterogeneity of human high-density lipoprotein (HDL) complexes is a determinant of its varied metabolic functions. To determine the structural heterogeneity of HDL, we determined major apolipoprotein stoichiometry profiles in human HDL. First, HDL was separated into two main populations, with and without apolipoprotein (apo) A-II, LpA-I and LpA-I/A-II, respectively. Each main population was further separated into six individual subfractions using size exclusion chromatography (SEC). Protein proximity profiles (PPPs) of major apolipoproteins in each individual subfraction was determined by optimally cross-linking apolipoproteins within individual particles with bis(sulfosuccinimidyl) suberate (BS(3)), a bifunctional cross-linker, followed by molecular mass determination by MALDI-MS. The PPPs of LpA-I subfractions indicated that the number of apoA-I molecules increased from two to three to four with an increase in the LpA-I particle size. On the other hand, the entire population of LpA-I/A-II demonstrated the presence of only two proximal apoA-I molecules per particle, while the number of apoA-II molecules varied from one dimeric apoA-II to two and then to three. For most of the PPPs described above, an additional population that contained a single molecule of apoC-III in addition to apoA-I and/or apoA-II was detected. Upon composition analyses of individual subpopulations, LpA-I/A-II exhibited comparable proportions for total protein (∼58%), phospholipids (∼21%), total cholesterol (∼16%), triglycerides (∼5%), and free cholesterol (∼4%) across subfractions. LpA-I components, on the other hand, showed significant variability. This novel information about HDL subfractions will form a basis for an improved understanding of particle-specific functions of HDL.

Indexed as

Apolipoprotein A-IApolipoprotein A-IIChromatography, GelElectrophoresisHumansLipoproteins, HDLSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationApolipoprotein A-IApolipoprotein A-IILipoproteins, HDL

Identifiers

PMID21073165
PMCPMC3006032
OpenAlexW2021160917

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.